Andrew Aromando

ONCY

Andrew Aromando serves as Chief Business Officer at Oncolytics Biotech Inc. (ONCY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$25.4K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$25.4K

Companies Traded

ONCY

Active Period

Feb 2026

1 total trades

Most Recent

Buy ONCY

Feb 11, 2026 · $25.4K

Andrew Aromando's Insider Trading at Oncolytics Biotech Inc. (ONCY)

Buys

1 · $25.4K

Sells

0 · $0.00

Total Shares Bought

29,600

Total Shares Sold

ONCY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 11, 2026↗	Buy	29,600	$0.86	$25.4K	0

Related Insiders

Patricia S Andrews

Director

ONCYBuy · Feb 12, 2026

Deborah Margaret Brown

Director

ONCYBuy · Feb 12, 2026

Allison Hagerman

VP, Product Development

ONCYBuy · Feb 12, 2026

Thomas Charles Heineman

Chief Medical Officer

ONCYBuy · Feb 12, 2026

Jared Kelly

Chief Executive Officer

ONCYBuy · Feb 12, 2026

Kirk Look

Chief Financial Officer

ONCYBuy · Feb 12, 2026

Wayne Pisano

Director

ONCYBuy · Feb 12, 2026

Bernd R. Seizinger

Director

ONCYBuy · Feb 12, 2026

Explore More Insider Trading Data

ONCY Insider Trading Activity

View all insider trades at Oncolytics Biotech Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity